Jim Hoffman: Affinity-Based Blood Purification as a Potential Alternative to Plasma Exchange
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn:
“A business model for improved therapeutic extracorporeal blood purification methods to follow that are capable of depleting toxic levels of extracellular chromatin from the blood.
These newer affinity-based methods , which effectively deplete extracellular chromatin and allow patients to keep their own blood with greatly reduced toxic levels of extracellular chromatin, should be evaluated as a replacement for more expensive and likely less effective Therapeutic Plasma Exchange (TPE).
This could greatly increase badly needed affordable access to treatment and potentially prevent and treat chronic illness disease progression more efficaciously than TPE.
A small sampling of the research implicating elevated extracellular chromatin contributing to multi-organ injury and disease progression:”
Find more posts featuring Jim Hoffman on Hemostasis Today.
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center
-
May 29, 2026, 17:20Martin Widschwendter: How Molecular Detection Tests Could Transform Endometrial Cancer Care
-
May 29, 2026, 17:18Nina Lansbury: Supporting a Period Friendly World With Menstrual Health Research and Education
-
May 29, 2026, 17:16Ipsita Chatterjee: Red is Not Shame, Red is Power, Red is a Woman
-
May 29, 2026, 16:49Abdulrahman Nasiri: The Evolving Role of Romiplostim in SAA
-
May 29, 2026, 16:46Soumen Bhattacharya: UC-II and Immune Modulation in Osteoarthritis
-
May 29, 2026, 16:38Ana Pedrero Gil: Red Blood Cell Transfusion Practice in Spain – High Inappropriateness Despite Low Overall Use
-
May 29, 2026, 15:40Lena Volland: Expanding Holistic Care in Bleeding Disorders Through Pelvic Health Physical Therapy at WFH Congress